Inclusion Bodies: Friends Or Foes? Development And Scale Up Of Insoluble, Microbially Expressed Biologics


The webinar delves into the use of inclusion bodies within biopharmaceutical production, which have gone from historically being considered undesirable byproducts of microbial expression systems to eventually gaining attention for their potential in producing a range of difficult to express proteins in E. coli systems.

The presentation aims to highlight the advantages of insoluble expression and address the challenges associated with purification. We also present and outline FUJIFILM Diosynth Biotechnologies’ approach to developing and scaling up these types of processes for a diverse range of biologics.

Key Learning Objectives:

  • Unraveling the friend aspect and overcoming the foe
  • Process Development strategies
  • Scale-up considerations and approaches
access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online

FUJIFILM Diosynth Biotechnologies